BOSTON — Patients with non-BRCA gene mutations undergoing risk-reduction surgery to prevent tubo-ovarian cancers showed no signs of tubo-ovarian high-grade serous carcinoma or serous tubal ...

CHICAGO -- Upfront surgery for advanced ovarian cancer failed to improve overall survival (OS) versus interval debulking but did improve progression-free survival (PFS) for the first time in a phase ...

Known as "the silent killer" due to its lack of symptoms and reliable screening tests, ovarian cancer remains one of the deadliest gynecologic cancers, claiming more than 12,000 lives annually.

Obesity is associated with increased surgical complications in EOC, including wound infections and intestinal problems, but not with overall survival differences. Meta-analysis showed obesity linked ...

AI models outperform traditional statistics in predicting post-complete cytoreduction outcomes in ovarian cancer patients. AI's diagnostic accuracy was high for predicting overall survival and no ...

Treating ovarian cancer remains a race against time. In Italy, eight out of ten women receive a late diagnosis, often when the disease is already at an advanced stage. To provide concrete ...

Atezolizumab versus placebo in combination with bevacizumab and non-platinum-based chemotherapy in recurrent ovarian cancer: Final overall and progression-free survival results from the AGO-OVAR ...

Surgery plays a critical role in the optimal management of all stages of ovarian carcinoma. In apparent early-stage ovarian cancer, a comprehensive surgical evaluation allows stratification of ...

HONOLULU — High-risk women who undergo prophylactic surgery to reduce ovarian cancer risk have few lingering worries about developing cancer in the future or regrets about their decision to undergo ...

Eligible patients can receive up to 70 per cent in subsidies for genetic tests, while MediShield Life coverage will be extended to selected risk-reducing surgical procedures.